LEXICON PHARMACEUTICALS, INC. — Director's Dealing 2016

Feb 16, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXICON PHARMACEUTICALS, INC. (LXRX)
CIK: 0001062822
Period of Report: 2016-02-11

Reporting Person: COATS LONNEL (Director, President and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-02-11	Stock Option (Right to Buy)	$8.20	A	134230	Acquired	2026-02-11	Common Stock (134230)	Direct
2016-02-11	Restricted Stock Units (Phantom Stock)	$	A	33560	Acquired		Common Stock (33560)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$11.76	2024-07-07	Common Stock (121928)	121928	Direct
Stock Option (Right to Buy)	$6.23	2025-02-05	Common Stock (173371)	173371	Direct
Restricted Stock Units (Phantom Stock)	$		Common Stock (43342)	43342	Direct

Footnotes

F1: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (2/11/2017) and vests 1/48th per month for each month of service thereafter.

F2: Each restricted stock unit represents a contingent right to receive one share of common stock.

F3: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter.

F4: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (7/7/2015) and vests 1/48th per month for each month of service thereafter.

F5: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (2/5/16) and vests 1/48th per month for each month of service thereafter.

F6: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2016 and vest an additional 25% on February 28 of each of the three succeeding years thereafter.